485 filings
Page 12 of 25
4
Adams Street Partners LLC
23 Mar 20
Change in insider ownership
4:03pm
8-K
CRVS
Corvus Pharmaceuticals Inc
20 Mar 20
Departure of Directors or Certain Officers
5:25pm
424B5
CRVS
Corvus Pharmaceuticals Inc
20 Mar 20
Prospectus supplement for primary offering
5:17pm
EFFECT
CRVS
Corvus Pharmaceuticals Inc
20 Mar 20
Notice of effectiveness
12:15am
CORRESP
CRVS
Corvus Pharmaceuticals Inc
17 Mar 20
Correspondence with SEC
12:00am
UPLOAD
CRVS
Corvus Pharmaceuticals Inc
12 Mar 20
Letter from SEC
12:00am
S-3
CRVS
Corvus Pharmaceuticals Inc
Shelf registration
9 Mar 20
5:12pm
10-K
2019 FY
CRVS
Corvus Pharmaceuticals Inc
Annual report
9 Mar 20
4:08pm
8-K
CRVS
Corvus Pharmaceuticals Inc
5 Mar 20
Corvus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2019 Financial Results
4:07pm
SC 13G/A
CRVS
Corvus Pharmaceuticals Inc
18 Feb 20
Beneficial ownership report (amended)
4:35pm
SC 13G/A
CRVS
Corvus Pharmaceuticals Inc
14 Feb 20
Corvus Pharmaceuticals, Inc.
2:52pm
SC 13G/A
CRVS
Corvus Pharmaceuticals Inc
14 Feb 20
Corvus Pharmaceuticals, Inc.
1:30pm
8-K
CRVS
Corvus Pharmaceuticals Inc
13 Feb 20
Regulation FD Disclosure
8:00am
SC 13G/A
Richard A Miller MD
12 Feb 20
Beneficial ownership report (amended)
4:07pm
8-K
CRVS
Corvus Pharmaceuticals Inc
3 Feb 20
Corvus Pharmaceuticals Presents Updated Clinical Data from its Phase 1/1b Clinical Trial of CPI-818 at the 12th Annual T-Cell Lymphoma Forum
8:00am
4
Erik J. Verner
16 Dec 19
Corvus Pharmaceuticals / Erik J. Verner ownership change
4:16pm
4
Mehrdad Mobasher
16 Dec 19
Corvus Pharmaceuticals / Mehrdad Mobasher ownership change
4:15pm
4
Richard A Miller MD
16 Dec 19
Corvus Pharmaceuticals / RICHARD A MD MILLER ownership change
4:14pm
4
CRVS
Corvus Pharmaceuticals Inc
16 Dec 19
Corvus Pharmaceuticals / LEIV LEA ownership change
4:13pm
4
William Benton Jones
16 Dec 19
Corvus Pharmaceuticals / William Benton Jones ownership change
4:12pm